Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas. β
Go to Publication β
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 79 Issue 3 Pages: 860-6 Pub: 2013 Feb Epub: 2012 Nov 26 Authors An C , Kuda T , Yazaki T , Takahashi H , Kimura B , |
|
|
The specific use of alginate from Laminaria japonica by Bacteroides species determined its modulation of the Bacteroides community. β
Go to Publication β
Food & function (Food Funct ) Vol: 10 Issue 7 Pages: 4304-4314 Pub: 2019 Jul 17 Epub: Authors Ai C , Jiang P , Liu Y , Duan M , Sun X , Luo T , Jiang G , Song S , |
|
|
The role of short-chain fatty acids in microbiota-gut-brain communication. β
Go to Publication β
Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , |
|
|
Physicochemical Properties of the Soluble Dietary Fiber from Laminaria japonica and Its Role in the Regulation of Type 2 Diabetes Mice. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 2 Pages: Pub: 2022 Jan 13 Epub: 2022 Jan 13 Authors Wang X , Zhang L , Qin L , Wang Y , Chen F , Qu C , Miao J , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
